CoChat

Functional role of angiotensin II AT2 receptor in modulation of AT1 receptor‐mediated contraction in rat uterine artery: involvement of bradykinin and nitric oxide

Open access
Hannan, Ruth E, Davis, Elizabeth A, Widdop, Robert E · 2003 · British Journal of Pharmacology
Cited by 92

The DOI matches its Crossref record.

Abstract

The aim of the present study was to explore the mechanisms underlying angiotensin II AT 2 receptor modulation of AT 1 receptor‐mediated vasoconstriction in the rat isolated uterine artery, since previous studies have suggested that AT 2 receptors may oppose AT 1 receptor‐mediated effects. Segments of uterine artery were obtained from Sprague–Dawley rats and mounted in small vessel myographs. Concentration–response (CR) curves to angiotensin II (0.1 n M–0.1 μM) were constructed in the absence and presence of PD 123319 (AT 2 antagonist; 1 μM), HOE 140 (bradykinin B 2 antagonist; 0.1 μM), Nω‐nitro‐L‐arginine (NOLA) (NOS inhibitor; 30 μM), as well as combinations of these inhibitors. Contractile responses to angiotensin II were expressed as a percent of the response to a K+ depolarizing solution. PD 123319 (1 μM) potentiated angiotensin II‐induced contractions; reflected by a significant four‐fold leftward shift of the angiotensin II CR curve. HOE 140 (0.1 μM) significantly increased the pEC 50 of the angiotensin II CR curve. The combination of HOE 140 plus PD 123319 did not produce additive potentiation. NOLA (30 μM) significantly enhanced sensitivity to angiotensin II, seen as a five‐fold leftward shift of the curve, and an augmented maximum contractile response. Combinations of PD 123319 (1 μM) plus NOLA, and of HOE 140 (0.1 μM) plus NOLA, both induced a similar magnitude of potentiation. Cyclic GMP measurements confirmed angiotensin II‐induced activation of the nitric oxide (NO) pathway. In conclusion, AT 2 receptor‐mediated inhibition of angiotensin II‐induced contraction of the rat uterine artery involves NO production; a component of which occurs through a bradykinin B 2 receptor pathway. British Journal of Pharmacology (2003) 140, 987–995. doi:10.1038/sj.bjp.0705484

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0705484

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 92

Metadata

Authors
Hannan, R. E., Davis, E. A., & Widdop, R. E.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2003-11
Volume
140
Issue
5
Pages
987-995
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2094428369
Cited by
92
References
0
FWCI
5.24
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Functional role of angiotensin II AT2 receptor in modulation of AT1 receptor‐mediated contraction in rat uterine artery: involvement of bradykinin and nitric oxide. https://app.cochat.ai/papers/10.1038/sj.bjp.0705484
The paper
Hannan, R. E., Davis, E. A., & Widdop, R. E. (2003). Functional role of angiotensin II AT2 receptor in modulation of AT1 receptor‐mediated contraction in rat uterine artery: involvement of bradykinin and nitric oxide. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0705484

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.